查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529691

血氣和電解質分析儀市場規模、佔有率、趨勢分析報告：按產品、最終用途、按地區、細分市場預測，2024-2030 年

Blood Gas And Electrolyte Analyzer Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables), By End-use (Clinical Laboratory, Point-of-care), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血液氣體和電解質分析儀市場成長和趨勢：

Grand View Research Inc.的一項新研究顯示，到2030年，全球血氣和電解質分析儀市場規模預計將達到37.1億美元，複合年成長率為4.5%。

ICU 和重症監護室患者數量的增加、對高通量和整合系統的需求不斷增加是可能推動血液氣體和電解質分析儀市場的主要因素。此外，全球老年人口的增加預計也將透過增加目標疾病的盛行率和擴大需要嚴重治療的患者基礎，對預測期內的市場成長做出重大貢獻。此外，由於測試選單的擴展和對可攜式設備的需求增加，預計多參數監測設備的出現將在預測期內推動利用率。血液氣體分析儀的出現有助於加強對重症患者的護理，透過頻繁診斷和監測呼吸系統疾病來指南預後和治療。對具有先進技術、可在短時間內進行測量的手持設備的需求不斷成長，導致更緊湊、更複雜的手持式照護現場設備的開發。例如，OPTI CCA-TS2 血氣和電解質分析儀採用創新的光學技術，只需最少的維護即可快速提供結果。

血氣和電解質分析儀市場報告亮點

  • 2023 年，消耗品將以 66.28% 的收益佔有率主導市場，預計在預測期內將以最快的成長率成長。
  • 2023年銷售佔有率為46.98%，臨床檢測佔市場主導地位。隨著醫療保健技術的快速發展，血液氣體分析儀 (BGA) 已成為臨床實驗室的重要組成部分，可即時了解患者​​的呼吸和代謝狀態。
  • 2023年北美佔血氣和電解質分析儀市場的42.22%。先進的醫療基礎設施和優惠的報銷計劃是預計推動該地區市場成長的主要因素。
  • 印度和中國新興市場存在大量未滿足的需求，加上醫療基礎設施的快速改善，預計將支持亞太地區在預測期內的良好成長率。對處理大量診斷測試的分散式照護現場診斷設施的需求不斷成長，預計也將推動該地區的市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章血氣與電解質分析儀市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 血氣和電解質分析儀市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章血氣和電解質分析儀市場：按產品估計和趨勢分析

  • 全球血液氣體和電解質分析儀市場：按產品分類的儀表板
  • 全球血液氣體和電解質分析儀市場：按產品分類的波動分析
  • 全球血氣及電解質分析儀市場：依產品、按收益
  • 裝置
  • 消耗品

第5章血氣和電解質分析儀市場：最終用途的估計和趨勢分析

  • 全球血液氣體和電解質分析儀市場：按最終用途分類的儀表板
  • 全球血液氣體和電解質分析儀市場：最終用途的變化分析
  • 全球血氣及電解質分析儀市場：依最終用途、按收益
  • 臨床實驗室
  • 照護現場
  • 診斷中心
  • 其他

第6章血氣和電解質分析儀市場：產品和最終用途的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Abbott
    • Meizhou Cornley High-Tech Co., Ltd.
    • Radiometer Medical ApS
    • EDAN Instruments, Inc.
    • Erba Mannheim
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostics
    • Werfen
    • LifeHealth
    • Medica Corporation
    • OPTI Medical Systems, Inc.,
    • Sensa Core
    • Siemens Healthineers AG
Product Code: 978-1-68038-420-8

Blood Gas And Electrolyte Analyzer Market Growth & Trends:

The global blood gas and electrolyte analyzer market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Blood Gas And Electrolyte Analyzer Market Report Highlights:

  • Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period, driven by their increasing demand.
  • Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights into a patient's respiratory and metabolic status.
  • North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
  • Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and end-use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Gas and Electrolyte Analyzer Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of chronic diseases
      • 3.2.1.2. Rising geriatric population
      • 3.2.1.3. Increasing regulatory support and funding
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced analyzers
      • 3.2.2.2. Shortage of skilled professionals
  • 3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Blood Gas and Electrolyte Analyzer Market: Product Estimates & Trend Analysis

  • 4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
  • 4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
  • 4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Instruments, by Type
    • 4.4.3. Bench Top
      • 4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.4. Portable
      • 4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.5. Instruments, by Brand
    • 4.4.6. I-STAT
      • 4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.7. epoc
      • 4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.8. GEM Premier (3500& 5000)
      • 4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.9. ABL Flex (90 and 800)
      • 4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.10. Cobas
      • 4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.11. Portable RAPID Series
      • 4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.12. Others
      • 4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Blood Gas and Electrolyte Analyzer Market: End Use Estimates & Trend Analysis

  • 5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
  • 5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
  • 5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
  • 5.4. Clinical Laboratory
    • 5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Point-of-care
    • 5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Blood Gas and Electrolyte Analyzer Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Singapore
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.7. Malaysia
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.8. Indonesia
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.9. Thailand
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.10. Vietnam
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.11. Philippines
      • 6.5.11.1. Key country dynamics
      • 6.5.11.2. Regulatory framework/ reimbursement structure
      • 6.5.11.3. Competitive scenario
      • 6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Meizhou Cornley High-Tech Co., Ltd.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Radiometer Medical ApS
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. EDAN Instruments, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Erba Mannheim
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. F. Hoffmann-La Roche Ltd
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Fortress Diagnostics
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Werfen
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. LifeHealth
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Medica Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. OPTI Medical Systems, Inc.,
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Sensa Core
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Siemens Healthineers AG
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Blood Gas and Electrolyte Analyzer, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 12 Canada Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Europe Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Germany Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 17 Germany Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 18 UK Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 19 UK Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 20 France Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 21 France Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Italy Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 23 Italy Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Spain Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 25 Spain Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Denmark Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Sweden Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 29 Sweden Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Norway Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 31 Norway Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 35 China Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 36 China Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Japan Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 38 Japan Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 39 India Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 40 India Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 41 South Korea Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 42 South Korea Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Australia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 44 Australia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Singapore Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 46 Singapore Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Malaysia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 48 Malaysia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Indonesia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 50 Indonesia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Thailand Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 52 Thailand Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Vietnam Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 54 Vietnam Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Philippines Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 56 Philippines Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Latin America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 58 Latin America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 59 Latin America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Brazil Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 61 Brazil Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Mexico Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 63 Mexico Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Argentina Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 65 Argentina Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 67 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 69 South Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 70 South Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 73 UAE Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 74 UAE Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Kuwait Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 76 Kuwait Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Gas and Electrolyte Analyzer Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
  • Fig. 16 Global Blood Gas and Electrolyte Analyzer Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Blood Gas and Electrolyte Analyzer Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
  • Fig. 19 Global Blood Gas and Electrolyte Analyzer Market, for Clinical Laboratory, 2018 - 2030 (USD Million)
  • Fig. 20 Global Blood Gas and Electrolyte Analyzer Market, for Point-of-care, 2018 - 2030 (USD Million)
  • Fig. 21 Global Blood Gas and Electrolyte Analyzer Market, for Diagnostic Centers, 2018 - 2030 (USD Million)
  • Fig. 22 Global Blood Gas and Electrolyte Analyzer Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Marketplace: Key Takeaways
  • Fig. 24 Regional Outlook, 2023 & 2030
  • Fig. 25 Global Blood Gas and Electrolyte Analyzer Market: Region Movement Analysis
  • Fig. 26 North America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 32 France Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 44 Singapore Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 45 Malaysia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 46 Indonesia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 48 Vietnam Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 49 Philippines Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)